Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation

BACKGROUND: Noopept (N-phenyl-acetyl-L-prolylglycine ethyl ester) was constructed as a dipeptide analog of the standard cognition enhancer, piracetam. Our previous experiments have demonstrated the cognition restoring effect of noopept in several animal models of Alzheimer disease (AD). Noopept was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostrovskaya, Rita U, Vakhitova, Yulia V, Kuzmina, Uliyana Sh, Salimgareeva, Milyausha Kh, Zainullina, Liana F, Gudasheva, Tatiana A, Vakhitov, Vener A, Seredenin, Sergey B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422191/
https://www.ncbi.nlm.nih.gov/pubmed/25096780
http://dx.doi.org/10.1186/s12929-014-0074-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422191/
https://www.ncbi.nlm.nih.gov/pubmed/25096780
http://dx.doi.org/10.1186/s12929-014-0074-2

Ejemplares similares